Table II.

Effects of Different Types of Drug Use at Baseline on Time to Linkage to HIV Care

Model parameter	n	HR [95% CI]
Model I
Any drug
No	33	Ref. Cat.
Yes	83	0.77 [0.50, 1.18]
Model II
Any stimulant
No	47	Ref. Cat.
Yes	69	0.67 [0.44, 1.00]*
Model III
Methamphetaminea
No	55	Ref. Cat.
Yes	60	0.63 [0.42, 0.94]*

Note. Data from participants who were in HIV care prior to enrollment in the study was excluded from the survival analyses (n = 13).

^aData from one participant who did not provide data on methamphetamine use was missing.

^*p ≤ .05.